Ray Dalio Bridgewater Associates
Ray Dalio is the founder of Bridgewater Associates, one of the world’s largest hedge funds, known for its unique “principles-based” culture and systematic investment approach. Dalio’s investment philosophy emphasizes diversified portfolios, risk parity, and the importance of understanding economic cycles in shaping investment decisions. He has authored several books, including “Principles: Life & Work,” in which he details his management philosophies, personal experiences, and life lessons.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$293M |
| 2 |
Microsoft
MSFT
|
+$216M |
| 3 |
ExxonMobil
XOM
|
+$92M |
| 4 |
Cameco
CCJ
|
+$87.2M |
| 5 |
Advanced Micro Devices
AMD
|
+$67.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$256M |
| 2 |
Eli Lilly
LLY
|
+$148M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$140M |
| 4 |
Comcast
CMCSA
|
+$88.8M |
| 5 |
Procter & Gamble
PG
|
+$83.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Staples | 18.04% |
| 2 | Healthcare | 14.75% |
| 3 | Technology | 14.42% |
| 4 | Consumer Discretionary | 12.13% |
| 5 | Communication Services | 8.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
751
Manhattan Associates
MANH
$11.4B
| $524K | ﹤0.01% |
+2,123
| New | +$481K |
|
752
Pediatrix Medical
MD
$2.2B
| $521K | ﹤0.01% |
69,048
-6,599
| -9% | -$54.6K |
|
753
W.W. Grainger
GWW
$60.2B
| $499K | ﹤0.01% |
+553
| New | +$520K |
|
754
Tandem Diabetes Care
TNDM
$1.56B
| $497K | ﹤0.01% |
12,336
-47,264
| -79% | -$1.97M |
|
755
Varex Imaging
VREX
$523M
| $489K | ﹤0.01% |
33,194
+4,614
| +16% | +$73.9K |
|
756
Humana
HUM
$46.2B
| $486K | ﹤0.01% |
1,301
-32,405
| -96% | -$10.9M |
|
757
Freeport-McMoran
FCX
$97.5B
| $477K | ﹤0.01% |
9,814
-12,180
| -55% | -$614K |
|
758
Paychex
PAYX
$42.7B
| $473K | ﹤0.01% |
+3,991
| New | +$488K |
|
|
NARI
759
DELISTED
Inari Medical, Inc. Common Stock
NARI
| $453K | ﹤0.01% |
9,413
-39,537
| -81% | -$1.75M |
|
760
Surgery Partners
SGRY
$2.03B
| $451K | ﹤0.01% |
+18,938
| New | +$486K |
|
761
ICU Medical
ICUI
$4.61B
| $450K | ﹤0.01% |
3,788
-836
| -18% | -$88K |
|
762
Danaher
DHR
$144B
| $449K | ﹤0.01% |
1,796
-6,785
| -79% | -$1.71M |
|
763
Enovis
ENOV
$1.53B
| $441K | ﹤0.01% |
9,765
-192
| -2% | -$9.96K |
|
764
West Fraser Timber
WFG
$5.65B
| $441K | ﹤0.01% |
5,746
+2,827
| +97% | +$224K |
|
765
Copart
CPRT
$27.5B
| $435K | ﹤0.01% |
8,036
-3,458
| -30% | -$189K |
|
766
Service Corp International
SCI
$11.6B
| $434K | ﹤0.01% |
+6,105
| New | +$433K |
|
|
P
767
Everpure Inc
P
$29.9B
| $434K | ﹤0.01% |
+6,759
| New | +$391K |
|
768
Phillips 66
PSX
$81.4B
| $427K | ﹤0.01% |
+3,028
| New | +$448K |
|
769
A.O. Smith
AOS
$8.7B
| $427K | ﹤0.01% |
5,221
+351
| +7% | +$29.7K |
|
770
CRH
CRH
$66.8B
| $426K | ﹤0.01% |
5,679
-5,986
| -51% | -$478K |
|
771
SharkNinja
SN
$26.1B
| $423K | ﹤0.01% |
+5,624
| New | +$396K |
|
772
Telus
TU
$15.3B
| $418K | ﹤0.01% |
27,619
-32,231
| -54% | -$519K |
|
773
W.R. Berkley
WRB
$26.6B
| $417K | ﹤0.01% |
+7,955
| New | +$426K |
|
|
CCRN
774
DELISTED
Cross Country Healthcare
CCRN
| $411K | ﹤0.01% |
29,716
-4,995
| -14% | -$79.1K |
|
775
Meritage Homes
MTH
$4.86B
| $410K | ﹤0.01% |
+5,070
| New | +$427K |
|
Similar funds
Ray Dalio's Q2 2024 Portfolio in Review
As of Q2 2024, Ray Dalio held 959 positions worth $19.2B, down 3.1% from $19.8B the previous quarter. Its ten largest holdings account for 35% of the portfolio.
Ray Dalio withdrew a net $757M in Q2 2024, closing 82 positions and reducing 390 holdings. Its most notable exit was Marathon Oil Corporation, an estimated $28.8M position sold in full.
By sector, the portfolio is most concentrated in Consumer Staples at 18% of assets, down from 19% a quarter earlier, followed by Healthcare and Technology.
Against the trend, Ray Dalio opened a new position in Constellation Energy worth $38.9M.
- Ray Dalio's largest Q2 2024 buy was Constellation Energy: 194,333 shares worth $38.9M.
- Ray Dalio added most to Amazon in Q2 2024, an estimated $293M increase.
- Ray Dalio's biggest Q2 2024 reduction was Apple, cutting an estimated $256M.
- Ray Dalio fully exited Marathon Oil Corporation in Q2 2024, selling an estimated $28.8M.
- Ray Dalio's ten largest holdings make up 35% of its $19.2B portfolio in Q2 2024.
- Ray Dalio opened 282 new positions and closed 82 in Q2 2024.
- Ray Dalio's portfolio value fell 3.1% quarter-over-quarter to $19.2B.
Based on Bridgewater Associates's 13F filing for Q2 2024, filed 14 Aug 2024.